For Immediate Release —
PORTLAND, OR, May 21, 2019/
The National Institutes of Health (NIH) has selected McCoy Russell, a preeminent women-owned intellectual property boutique law firm based on the West Coast, to provide biotechnology patent legal services under a ten-year contract.
The NIH is a U.S. governmental agency that conducts research related to health and is the largest biomedical research agency in the world, investing billions every year in medical research. NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The inventions developed by the NIH have led to thousands of patent applications, with many licensed to industry and impacting the lives of millions.
McCoy Russell is one of a small, select, group of firms authorized to provide patent legal services to the NIH. “The NIH is one of the most selective patent filers in the area of biotechnology and we are humbled to have been selected to work with their world-leading inventors to advance new technologies that will impact peoples’ lives,” said Anna McCoy, founding partner at McCoy Russell LLP and one of the leaders of the firm’s biotechnology practice.
A women-owned technology-focused law firm that often flies under the radar, McCoy Russell’s unique firm model has led to numerous national rankings for quality and effectiveness in the area of intellectual property preparation, prosecution, and development.
McCoy Russell LLP is a nationally ranked boutique, woman-owned, intellectual property law firm headquartered in Portland, Oregon and focused on the prosecution and development of patent and trademark portfolios. www.mccrus.com